Drs. Collins and Gibbons discuss the launch of adaptive clinical trials of blood clotting treatments for COVID-19 | National Institutes of Health (NIH)

Drs. Collins and Gibbons discuss the launch of adaptive clinical trials of blood clotting treatments for COVID-19 | National Institutes of Health (NIH)

Drs. Collins and Gibbons discuss the launch of adaptive clinical trials of blood clotting treatments for COVID-19

In a live conversation on Facebook and Twitter, Dr. Collins and NHLBI Director Dr. Gary Gibbons discuss the launch of Phase 3 clinical trials to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19.

https://www.youtube.com/watch